Which study helps assess cancer risk in suspected BPH?

Which study helps assess cancer risk in suspected BPH?

• A. Urinalysis
• B. Prostate-specific antigen
• C. Uroflowmetry
• D. Renal ultrasound

Answer: (B)

Measuring PSA helps assess cancer risk in suspected BPH. Prostate-specific antigen is a protein produced by prostate cells, and higher levels raise suspicion for prostate cancer (even though elevations can also occur with benign prostatic hyperplasia or prostatitis). In men with suspected BPH, PSA testing helps gauge cancer risk and guide decisions about whether a biopsy is needed. The other studies serve different purposes: urinalysis checks for infection or blood in the urine, uroflowmetry evaluates the degree of bladder outlet obstruction, and renal ultrasound looks at kidney structure and hydronephrosis, not cancer risk.

Measuring PSA helps assess cancer risk in suspected BPH. Prostate-specific antigen is a protein produced by prostate cells, and higher levels raise suspicion for prostate cancer (even though elevations can also occur with benign prostatic hyperplasia or prostatitis). In men with suspected BPH, PSA testing helps gauge cancer risk and guide decisions about whether a biopsy is needed. The other studies serve different purposes: urinalysis checks for infection or blood in the urine, uroflowmetry evaluates the degree of bladder outlet obstruction, and renal ultrasound looks at kidney structure and hydronephrosis, not cancer risk.